One of the most recent studies suggested that diabetics may be in higher danger of developing a dangerous Staph infection, in comparison to those without diabetes.
Staph infections, medically known as Staphylococcus aureu bacteria, is a common bacteria typically living on human’s skin without posing any threat. However, it can cause a dangerous blood disease. On other words, it can be harmful and lethal once it enters our bloodstream.
It is revealed that the 30-day death rate from such infections is 20 to 30 percent, as the study conducted by the researchers from Aalborg University Hospital and Aarhus University Hospital. They tracked the medical records of 30,000 people in Denmark over the course of 12 years.
The result implied that diabetics in any forms have a nearly 3 times increased risk of Staph infections acquired outside of a hospital.
Specifically, compared with people without diabetes, type-1 diabetics were more than 7 times more at risk of a Staph infection while people with type-2 diabetics were almost 3 times more at risk.
Otherwise, a combination of diabetes and kidney problems increased the risk of the infection by 4 times. Diabetes together with complications, including heart and circulation problems as well as diabetic ulcers, also faced a greater risk of the infection.
The number of years a person had had the disease also have impact on the risk since those who were with diabetes for at least 10 years were almost 4 times at risk. Poor control over the disease is found to be a contribution to a greater risk of Staph infection.
“It has long been a common clinical belief that diabetes increases the risk of S.aureus infection, but until now this has been supported by scant evidence,” said lead researcher Jesper Smit in a journal news release.
“Poor management of diabetes can lead to an impaired immune response. This may be the reason why diabetes patients are at higher risk of infection. Similarly, diabetic patients often suffer associated illnesses – the burden of multiple healthcare problems can also increase susceptibility to infection,” added Smit.
The authors say the findings could indicate a need for greater infection surveillance among long-term diabetes patients, however there were some limitations to their study, including being unable to account for smoking or body mass index. These two may affect the immune response and possible infection in the future.
The study was published on March 10 in the European Journal of Endocrinology.